USBN Q1 2018- CeFO version

24 US BUSINESS NEWS / Q1 2018 , of our medical and strategy teams and CEO; our award-winning scientific agency has brought our FUTURING service offering to our clients for over the past half-decade, which clients have integrated into their business strategy to create goals and drive decision-making that side-step global crisis and are impactful in many ways including: in the development of new therapeutic brands, in providing a more personalized brand experience for patients, and in transforming patient health outcomes.” Ultimately, Simpson Healthcare will look to continue to disrupt the healthcare market, providing new solutions daily and establishing itself as a leader within the healthcare industry. Danielle signs off by predicting a bright future ahead for Simpson Healthcare, as this exciting team look to explore a wealth of new opportunities and avenues within the sector. “Moving forward, the core stories of disease, diagnosis, and new therapies will continue to be new, disruptive, and abundant. We see huge opportunity to continue to build knowledge and skills in organizing and showcasing scientific content. We will have more brands to build and more ways to build them and explain them. We believe we will be SimpsonHealthcare is anestablished scientific agencyproviding the pharmaceutical, biotechnology,medical diagnostic anddevice industrieswithawide range of services in support of overallmarketing strategies. DanielleGallagher gives us an inside viewof this innovative and successful company. Embracing the Future Founded in 1998, Simpson Healthcare challenges key stakeholders in the healthcare industry to think differently about healthcare beyond next year and into the next decade, unlocking client’s full potential to most positively impact patients who could benefit most from their therapies. Danielle outlines the overall mission of Simpson Healthcare, expanding on how the leadership team has revamped the company, looking towards the future. “Under the transformative guidance of Kelly Simpson-Angelini, the leadership team revisited the mission and vision of Simpson Healthcare a few years ago, transforming this into a purpose statement; which is rooted in our internal core belief systems, guides our teams in every moment, and is the reason why we do what we do every day at our agency. Our purpose is to help our clients to share the scientific story of the diseases we touch and therapies discovered for all in need. We are proud to stand united with our clients as we help them to improve the quality of life for patients who will benefit most from their therapies.” Amajor player in the healthcare industry, Simpson Healthcare works with biopharmaceutical clients to provide the best results for clients and reach the desired outcome for both sides. Danielle comments on the firm’s launch of its new line of work with clients, and what strategies the business has in place to continue its success. “Recently, we have launched a new line of FUTURING work, where we look at key datasets, healthcare trends, global policies, and beliefs into the next 10-20 years to support our clients in the development of new treatments, in delivering more personalised and precise medicine, and in strengthening the health of their brands. The scientific expertise and disruptive thinking methods and behaviours among the elite members of Simpson Healthcare span across a broad array of many major therapeutic categories, including respiratory, oncology, cardiovascular, immunology, rare diseases, gastrointestinal, adult vaccines, and severe asthma, to name a few. Our medical and strategy teams have effectively become known as catalysts of industry innovation as we bring to bear the larger context of healthcare for our clients, aligned in our purpose, and always keeping the patient at the core of our focus.” With all members of the team possessing a wealth of expertise and knowledge, Danielle mentions what the team believes to be the key to the company’s success. “Interestingly, we believe that the success of our award-winning scientific agency is driven by our collaborative internal beliefs about healthcare and what delivering patient-centered care means, we work to fulfil the overarching purpose of healthcare in what we do every day: to help people live better. Our dedication to physician education and providing personalized, precision medicine has revolutionized a broad array of therapeutic areas that we have touched, and improved quality of life for patients across the globe.” Innovation is a key part of the company’s success, and it is the creativeness of the team alongside its desire to put the client first which helps Simpson Healthcare to stand out amongst its competitors, as Danielle mentions, alluding to the FUTURING offering which is unrivalled in the market. “Deeply mindful of the importance of improving healthcare for patients, Simpson Healthcare has worked to pioneer sales offerings that are new to the pharmaceutical industry; and cannot be matched by other advertising and marketing agencies and work to efficiently support the future of science for our clients’ business. With the support NAE18006